Emery-dreifuss autosomal recessive muscular dystrophy is a rare syndrome that primarily affects cardiac muscles and muscles used for movement. Symptoms of Emery-dreifuss autosomal recessive muscular dystrophy such as restriction of movement of certain joints such as the elbows, ankles, and neck and muscle wasting in the upper arms and lower legs appear in early childhood and worsen over time. By adulthood, most individuals with the disorder have heart problems such as cardiac conduction defects and arrhythmias. Emery-dreifuss autosomal recessive muscular dystrophy is caused by mutations in the LMNA gene and is inherited in an autosomal recessive manner. There is no cure for Emery-dreifuss autosomal recessive muscular dystrophy.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy, Emery-dreifuss, Autosomal Recessive below!
For more information on how to use Laverne, please read the How to Guide.
We have 223 products for the study of Muscular Dystrophy, Emery-dreifuss, Autosomal Recessive that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Muscular Dystrophy, Emery-dreifuss, Autosomal Recessive is also known as Autosomal Recessive Emery-dreifuss Muscular Dystrophy.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.